Dynavax Technologies Corporation

Company Listings from SPi: Dynavax Technologies Corporation

You are here: Home >> SPi Company Listings >> Dynavax Technologies Corporation

 

Dynavax Technologies Corporation

Website:
http://

Search for other references to "dynavax" on SPi News

Latest Dynavax Technologies Corporation News

Dynavax Announces Andrew Hack, M.D., Ph.D., Has Joined Board of Directors EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, today announced Andrew A. F. Hack, M...... 21:05 GMT Monday 12th August 2019

Dynavax Technologies Announces Pricing of $70.1 Million Public Offering of Common Stock, Non Voting Preferred Stock and Warrants to Purchase Common Stock EMERYVILLE, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, develo...... 13:00 GMT Thursday 8th August 2019

Dynavax Technologies Announces Proposed Public Offering of Common Stock, Non-Voting Preferred Stock and Warrants to Purchase Common Stock EMERYVILLE, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, develo...... 21:12 GMT Wednesday 7th August 2019

Dynavax Announces Second Quarter 2019 Financial Results EMERYVILLE, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, today reported financial results for...... 21:01 GMT Wednesday 7th August 2019

Dynavax Technologies to Report Second Quarter 2019 Financial Results and Host Conference Call on August 7 BERKELEY, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on developing novel vacc...... 21:05 GMT Wednesday 24th July 2019

Dynavax to Present at the William Blair & Co. Annual Growth Stock Conference   BERKELEY, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: DVAX), today announced that Ryan Spencer, Senior Vice President, Commercial, and Interim Co-President, will present...... 21:05 GMT Monday 3rd June 2019

Overall Response Rate of 76% in Advanced Melanoma Patients with Dynavax’s SD-101 in Combination with KEYTRUDA® (pembrolizumab); Data Presented Today at the 2019 ASCO Annual Meeting BERKELEY, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: DVAX), today announced increasingly favorable results from the Phase 1b/2 (SYNERGY-001), open-label, multicenter stu...... 19:15 GMT Monday 3rd June 2019

Dynavax Presents Phase 2 Data on SD-101 in Combination with KEYTRUDA® (pembrolizumab) for Patients with Head and Neck Squamous Cell Carcinoma at the 2019 ASCO Annual Meeting BERKELEY, Calif., June 01, 2019 (GLOBE NEWSWIRE) --   (NASDAQ: DVAX), today announced favorable results from the Phase 2 cohort expansion of the Phase 1b/2, open-label, multicen...... 19:15 GMT Saturday 1st June 2019

Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business BERKELEY, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: DVAX), today announced a strategic restructuring to prioritize its vaccine business by focusing on the company’s fi...... 21:45 GMT Thursday 23rd May 2019

Dynavax Announces First Quarter 2019 Financial Results BERKELEY, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel vacc...... 21:05 GMT Wednesday 8th May 2019

Buy Dynavax Technologies Corporation
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us